Akero Therapeutics Inc (AKRO)

Stock price, financials, and technical signals for Akero Therapeutics Inc (AKRO).

$54.00

2.53

(4.92%)

As of 01/29/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

AKRO Performance Snapshot


1-Week Chg

115.83%

1-Month Chg

91.15%

3-Month Chg

70.19%

6-Month Chg

99.85%

1-Year Chg

129.10%

Year-To-Date Chg

92.31%

Beta 1-Year

0.64

Beta 5-Year

-0.24

Volatility (10-Day)

38.15%

AKRO Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-01-29

$54

$2.53 (4.92%)

$52.48

$55.74

$51.79

$53.84

3.56M ($192.09M)

2025-01-28

$51.47

-$0.24 (-0.46%)

$54.63

$57.48

$49.38

$52.78

5.23M ($269.13M)

2025-01-27

$51.71

$25.53 (97.52%)

$57.26

$58.40

$48.47

$52.86

15.27M ($789.63M)

2025-01-24

$26.18

$0.02 (0.08%)

$26.11

$26.47

$25.69

$26.11

1.27M ($33.28M)

2025-01-23

$26.16

$1.14 (4.56%)

$24.77

$26.23

$24.69

$25.69

632.07K ($16.53M)

2025-01-22

$25.02

-$0.58 (-2.27%)

$25.60

$25.95

$24.73

$25.23

876.75K ($21.94M)

2025-01-21

$25.60

$0.46 (1.83%)

$25.60

$26.20

$25.25

$25.68

1.16M ($29.65M)

2025-01-17

$25.14

$1.13 (4.71%)

$24.33

$25.63

$24.05

$24.94

1.23M ($30.90M)

2025-01-16

$24.01

$1.70 (7.62%)

$22.18

$24.34

$22.05

$23.47

1.26M ($30.23M)

2025-01-15

$22.31

$0.44 (2.01%)

$22.61

$22.74

$21.97

$22.34

750.80K ($16.75M)

AKRO Financials


Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE


  • Cash and equivalents

    $316.06M

    17.26%

  • Total assets

    $817.55M

    28.68%

  • Total liabilities

    $79.22M

    51.78%

  • Total investments

    $471.01M

    37.14%

  • Shareholders' equity

    $738.33M

    26.61%

  • Book value per share

    $10.63

    1.39%


Income Statement

(USD)

2024 Q3

Y/Y CHANGE


  • Revenue

    $0

    0%

  • Net income

    -$72.70M

    -83.33%

  • Operating expense

    $81.70M

    75.27%

  • Gross profit

    $0

    0%

  • EBITDA

    -$71.39M

    -84.45%

  • Earnings per share

    -$1.05

    -47.89%


Cash Flow

(USD)

2024 Q3

Y/Y CHANGE


  • Net change in cash

    $5.71M

    103.27%

  • Cash from operations

    -$70.42M

    -41.64%

  • Cash from investing

    $73.07M

    158.13%

  • Cash from financing

    $3.07M

    280.52%

  • Free cash flow

    -$70.42M

    -41.64%

  • Free cash flow per share

    -$1.01

    -13.42%


Metrics

(USD)

2024 Q3

Y/Y CHANGE


  • Market capitalization

    $1.99B

    -29.17%

  • Enterprise value

    $1.72B

    -28.27%

  • Shares outstanding

    69.43M

    24.87%

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -


Dividends

(USD)

2024 Q3

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    17.25

    -14.79%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.